All In Biotech

Drug Trial Radar · NCT06775379

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 357 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

357

Actual

Start

Dec 20, 2024

Primary completion

Oct 28, 2026

Study completion Oct 28, 2026

Sponsor

Lead sponsor
Xenon Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Jan 15, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)

Conditions

  • Major Depressive Disorder

Interventions

  • AzetukalnerDrug

    Azetukalner 20 mg taken orally once a day with food (with the evening meal when possible) for 6 weeks

  • PlaceboDrug

    Placebo taken orally once a day with food (with the evening meal when possible) for 6 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in the Hamilton Depression Rating Scale, 17-item (HAMD-17) score at Week 6Time frame: Baseline to Week 6

Locations

45 sites in 1 country. Site status is shown where the registry gives one.

  • IMA Clinical Research Phoenix

    Phoenix, Arizona

  • Woodland International Research Group

    Little Rock, Arkansas

  • Woodland Research Northwest

    Rogers, Arkansas

  • Irvine Clinical Research

    Irvine, California

  • CalNeuro Research Group, Inc.

    Los Angeles, California

  • Excell Research Inc.

    Oceanside, California

  • Atp Clinical Research

    Orange, California

  • Nrc Research Institute

    Orange, California

  • CenExel CNS-TO (Collaborative Neuroscience Research)

    Torrance, California

  • Sunwise Clinical Research

    Walnut Creek, California

  • Kinetic Clinical Research, LLC

    West Covina, California

  • Ct Clinical Research Associates

    Cromwell, Connecticut

  • CNS Clinical Research Group

    Coral Springs, Florida

  • NeoClinical Research

    Hialeah, Florida

  • Clinical Neuroscience Solutions, LLC

    Jacksonville, Florida

  • Accel Research Sites Lakeland

    Lakeland, Florida

  • Accel Research Sites - St. Petersburg-Largo

    Largo, Florida

  • PharmaSouth Research

    Miami, Florida

  • Quantum Clinical Trials

    Miami Beach, Florida

  • Harmony Clinical Research Inc

    North Miami Beach, Florida

  • Clinical Neuroscience Solutions, LLC

    Orlando, Florida

  • Combined Research Orlando Phase I-Iv

    Orlando, Florida

  • Panhandle Research and Medical Clinic

    Pensacola, Florida

  • Advanced Discovery Research

    Atlanta, Georgia

  • Synexus - Atlanta

    Atlanta, Georgia

  • CenExel iResearch

    Decatur, Georgia

  • Psych Atlanta, Pc

    Marietta, Georgia

  • Cenexel Iresearch - Savannah

    Savannah, Georgia

  • Northwest Clinical Trials Inc

    Boise, Idaho

  • IMA Clinical Research

    Chicago, Illinois

  • Boston Clinical Trials Llc

    Boston, Massachusetts

  • ELIXIA

    Springfield, Massachusetts

  • IMA Clinical Research Las Vegas

    Las Vegas, Nevada

  • Redbird Research

    Las Vegas, Nevada

  • Integrative Clinical Trials

    Brooklyn, New York

  • Richmond Behavioral Associates

    Staten Island, New York

  • New Hope Clinical Research

    Charlotte, North Carolina

  • Neuro-Behavioral Clinical Research

    North Canton, Ohio

  • Pahl Pharmaceutical Professionals Llc

    Oklahoma City, Oklahoma

  • Lehigh Center For Clinical Research

    Allentown, Pennsylvania

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.